{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:51:31Z","timestamp":1765889491237,"version":"3.40.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01704-w","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T04:24:15Z","timestamp":1745814255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of causal effects on metabolic syndrome and inflammatory bowel disease: a Mendelian randomization study"],"prefix":"10.1186","volume":"17","author":[{"given":"Danyang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongcao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3192-0400","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"1704_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.12229","volume":"16","author":"S O\u2019Neill","year":"2015","unstructured":"O\u2019Neill S, O\u2019Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1\u201312.","journal-title":"Obes Rev"},{"doi-asserted-by":"crossref","unstructured":"Scott M. Grundy. Metabolic Syndrome Pandemic. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:629\u201336.","key":"1704_CR2","DOI":"10.1161\/ATVBAHA.107.151092"},{"key":"1704_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4103\/1319-3767.87177","volume":"17","author":"E Yorulmaz","year":"2011","unstructured":"Yorulmaz E, Adali G, Yorulmaz H, Ulasoglu C, Tasan G, Tuncer I. Metabolic syndrome frequency in inflammatory bowel diseases. Saudi J Gastroenterol. 2011;17:376\u201382.","journal-title":"Saudi J Gastroenterol"},{"key":"1704_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000380763","volume":"91","author":"PS Fitzmorris","year":"2015","unstructured":"Fitzmorris PS, Colantonio LD, Torrazza Perez E, Smith I, Kakati DD, Malik TA. Impact of metabolic syndrome on the hospitalization rate of Crohn\u2019s disease patients seen at a tertiary care center: a retrospective cohort study. Digestion. 2015;91:257\u201362.","journal-title":"Digestion"},{"key":"1704_CR5","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769\u201378.","journal-title":"Lancet"},{"key":"1704_CR6","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/ueg2.12350","volume":"10","author":"S Aniwan","year":"2022","unstructured":"Aniwan S, Santiago P, Loftus EV, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United Eur Gastroenterol J. 2022;10:1063\u201376.","journal-title":"United Eur Gastroenterol J"},{"key":"1704_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/MIB.0000000000000289","volume":"21","author":"LJ Dixon","year":"2015","unstructured":"Dixon LJ, Kabi A, Nickerson KP, McDonald C. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis. 2015;21:912\u201322.","journal-title":"Inflamm Bowel Dis"},{"key":"1704_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41575-020-0354-0","volume":"17","author":"WA Goodman","year":"2020","unstructured":"Goodman WA, Erkkila IP, Pizarro TT. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17:740\u201354.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1704_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2468-1253(19)30173-6","volume":"4","author":"M Argollo","year":"2019","unstructured":"Argollo M, Gilardi D, Peyrin-Biroulet C, Chabot J-F, Peyrin-Biroulet L, Danese S. Comorbidities in inflammatory bowel disease: a call for action. Lancet Gastroenterol Hepatol. 2019;4:643\u201354.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1704_CR10","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization JAMA. 2017;318:1925\u20136.","journal-title":"Mendelian Randomization JAMA"},{"key":"1704_CR11","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","journal-title":"BMJ"},{"key":"1704_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/ije\/dyab251","volume":"51","author":"A Hartley","year":"2022","unstructured":"Hartley A, Sanderson E, Granell R, Paternoster L, Zheng J, Smith GD, et al. Using multivariable Mendelian randomization to estimate the causal effect of bone mineral density on osteoarthritis risk, independently of body mass index. Int J Epidemiol. 2022;51:1254\u201367.","journal-title":"Int J Epidemiol"},{"key":"1704_CR13","doi-asserted-by":"publisher","first-page":"921546","DOI":"10.3389\/fimmu.2022.921546","volume":"13","author":"B Liu","year":"2022","unstructured":"Liu B, Ye D, Yang H, Song J, Sun X, Mao Y, et al. Two-Sample Mendelian randomization analysis investigates causal associations between gut microbial genera and inflammatory bowel disease, and specificity causal associations in ulcerative colitis or Crohn\u2019s disease. Front Immunol. 2022;13:921546.","journal-title":"Front Immunol"},{"key":"1704_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","volume":"181","author":"S Burgess","year":"2015","unstructured":"Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181:251\u201360.","journal-title":"Am J Epidemiol"},{"key":"1704_CR15","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood Institute scientific statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"1704_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40:740\u201352.","journal-title":"Int J Epidemiol"},{"key":"1704_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KGMM Alberti","year":"2006","unstructured":"Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome\u2013a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469\u201380.","journal-title":"Diabet Med"},{"key":"1704_CR18","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23:786.","journal-title":"Int J Mol Sci"},{"key":"1704_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12328-019-01037-y","volume":"13","author":"A Szilagyi","year":"2020","unstructured":"Szilagyi A. Relationship(s) between obesity and inflammatory bowel diseases: possible intertwined pathogenic mechanisms. Clin J Gastroenterol. 2020;13:139\u201352.","journal-title":"Clin J Gastroenterol"},{"key":"1704_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","volume":"152","author":"GG Kaplan","year":"2017","unstructured":"Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152:313\u2013e3212.","journal-title":"Gastroenterology"},{"key":"1704_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/ecco-jcc\/jjac193","volume":"17","author":"Y Je","year":"2023","unstructured":"Je Y, Han K, Chun J, Kim Y, Kim J-H, Hoon Youn Y, et al. Association of waist circumference with the risk of inflammatory bowel disease: a nationwide cohort study of 10 million individuals in Korea. J Crohns Colitis. 2023;17:681\u201392.","journal-title":"J Crohns Colitis"},{"key":"1704_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cgh.2021.06.049","volume":"20","author":"SSM Chan","year":"2022","unstructured":"Chan SSM, Chen Y, Casey K, Olen O, Ludvigsson JF, Carbonnel F, et al. Obesity is associated with increased risk of Crohn\u2019s disease, but not ulcerative colitis: A pooled analysis of five prospective cohort studies. Clin Gastroenterol Hepatol. 2022;20:1048\u201358.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1704_CR23","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.3390\/ijms21249564","volume":"21","author":"Y-W Tsai","year":"2020","unstructured":"Tsai Y-W, Fu S-H, Dong J-L, Chien M-W, Liu Y-W, Hsu C-Y, et al. Adipokine-Modulated immunological homeostasis shapes the pathophysiology of inflammatory bowel disease. Int J Mol Sci. 2020;21:9564.","journal-title":"Int J Mol Sci"},{"key":"1704_CR24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0899-9007(01)00672-4","volume":"17","author":"UN Das","year":"2001","unstructured":"Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17:953\u201366.","journal-title":"Nutrition"},{"key":"1704_CR25","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.3390\/ijms22084226","volume":"22","author":"E Karaskova","year":"2021","unstructured":"Karaskova E, Velganova-Veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D. Role of adipose tissue in inflammatory bowel disease. Int J Mol Sci. 2021;22:4226.","journal-title":"Int J Mol Sci"},{"key":"1704_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MIB.0000000000000209","volume":"21","author":"P Gon\u00e7alves","year":"2015","unstructured":"Gon\u00e7alves P, Magro F, Martel F. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis. 2015;21:453\u201367.","journal-title":"Inflamm Bowel Dis"},{"key":"1704_CR27","doi-asserted-by":"publisher","first-page":"e78495","DOI":"10.1371\/journal.pone.0078495","volume":"8","author":"A Zulian","year":"2013","unstructured":"Zulian A, Cancello R, Ruocco C, Gentilini D, Di Blasio AM, Danelli P, et al. Differences in visceral fat and fat bacterial colonization between ulcerative colitis and Crohn\u2019s disease. An in vivo and in vitro study. PLoS ONE. 2013;8:e78495.","journal-title":"PLoS ONE"},{"key":"1704_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10606820213687","volume":"8","author":"PL Brubaker","year":"2002","unstructured":"Brubaker PL, Drucker DJ. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Recept Channels. 2002;8:179\u201388.","journal-title":"Recept Channels"},{"key":"1704_CR29","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1007\/s00125-012-2592-3","volume":"55","author":"Y-S Lee","year":"2012","unstructured":"Lee Y-S, Park M-S, Choung J-S, Kim S-S, Oh H-H, Choi C-S, et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia. 2012;55:2456\u201368.","journal-title":"Diabetologia"},{"key":"1704_CR30","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.3748\/wjg.v30.i43.4682","volume":"30","author":"M Guney-Coskun","year":"2024","unstructured":"Guney-Coskun M, Basaranoglu M. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: new frontiers in metabolic dysfunction-associated steatotic liver disease therapy. World J Gastroenterol. 2024;30:4682\u20138.","journal-title":"World J Gastroenterol"},{"key":"1704_CR31","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.3748\/wjg.v29.i33.4991","volume":"29","author":"KL Francis","year":"2023","unstructured":"Francis KL, Alonge KM, Pacheco MC, Hu SJ, Krutzsch CA, Morton GJ, et al. Diabetes exacerbates inflammatory bowel disease in mice with diet-induced obesity. World J Gastroenterol. 2023;29:4991\u20135004.","journal-title":"World J Gastroenterol"},{"key":"1704_CR32","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1021\/acs.molpharmaceut.8b00332","volume":"15","author":"W Wu","year":"2018","unstructured":"Wu W, Wang S, Liu Q, Shan T, Wang Y. Metformin protects against LPS-Induced intestinal barrier dysfunction by activating AMPK pathway. Mol Pharm. 2018;15:3272\u201384.","journal-title":"Mol Pharm"},{"key":"1704_CR33","doi-asserted-by":"publisher","first-page":"652709","DOI":"10.3389\/fimmu.2021.652709","volume":"12","author":"S Yang","year":"2021","unstructured":"Yang S, Park J-S, Hwang S-H, Cho K-H, Na HS, Choi J, et al. Metformin-Inducible small heterodimer partner interacting leucine zipper protein ameliorates intestinal inflammation. Front Immunol. 2021;12:652709.","journal-title":"Front Immunol"},{"key":"1704_CR34","doi-asserted-by":"publisher","first-page":"109230","DOI":"10.1016\/j.intimp.2022.109230","volume":"112","author":"W Wanchaitanawong","year":"2022","unstructured":"Wanchaitanawong W, Thinrungroj N, Chattipakorn SC, Chattipakorn N, Shinlapawittayatorn K. Repurposing Metformin as a potential treatment for inflammatory bowel disease: evidence from cell to the clinic. Int Immunopharmacol. 2022;112:109230.","journal-title":"Int Immunopharmacol"},{"key":"1704_CR35","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1007\/s43440-021-00327-y","volume":"73","author":"H Zatorski","year":"2021","unstructured":"Zatorski H, Salaga M, Zieli\u0144ska M, Mokrowiecka A, Jacenik D, Krajewska WM, et al. Colonic inflammation induces changes in glucose levels through modulation of incretin system. Pharmacol Rep. 2021;73:1670\u20139.","journal-title":"Pharmacol Rep"},{"key":"1704_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/01.MIB.0000195975.97673.f5","volume":"12","author":"N Bregenzer","year":"2006","unstructured":"Bregenzer N, Hartmann A, Strauch U, Sch\u00f6lmerich J, Andus T, Bollheimer LC. Increased insulin resistance and beta cell activity in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2006;12:53\u20136.","journal-title":"Inflamm Bowel Dis"},{"key":"1704_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ueg2.12351","volume":"11","author":"J He","year":"2023","unstructured":"He J, Zhang S, Qiu Y, Liu F, Liu Z, Tan J, et al. Ulcerative colitis increases risk of hypertension in a UK biobank cohort study. United Eur Gastroenterol J. 2023;11:19\u201330.","journal-title":"United Eur Gastroenterol J"},{"key":"1704_CR38","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.jacc.2020.10.027","volume":"76","author":"M Cainzos-Achirica","year":"2020","unstructured":"Cainzos-Achirica M, Glassner K, Zawahir HS, Dey AK, Agrawal T, Quigley EMM, et al. Inflammatory bowel disease and atherosclerotic cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2020;76:2895\u2013905.","journal-title":"J Am Coll Cardiol"},{"key":"1704_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00063-018-0475-1","volume":"113","author":"W Druml","year":"2018","unstructured":"Druml W. [Intestinal cross-talk: the gut as motor of multiple organ failure]. Med Klin Intensivmed Notfmed. 2018;113:470\u20137.","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"1704_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.309006","volume":"120","author":"MM Santisteban","year":"2017","unstructured":"Santisteban MM, Qi Y, Zubcevic J, Kim S, Yang T, Shenoy V, et al. Hypertension-Linked pathophysiological alterations in the gut. Circ Res. 2017;120:312\u201323.","journal-title":"Circ Res"},{"key":"1704_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14.","journal-title":"Microbiome"},{"key":"1704_CR42","doi-asserted-by":"publisher","first-page":"112787","DOI":"10.1016\/j.biopha.2022.112787","volume":"149","author":"Z Yang","year":"2022","unstructured":"Yang Z, Liu Y, Wang L, Lin S, Dai X, Yan H, et al. Traditional Chinese medicine against COVID-19: role of the gut microbiota. Biomed Pharmacother. 2022;149:112787.","journal-title":"Biomed Pharmacother"},{"key":"1704_CR43","doi-asserted-by":"publisher","first-page":"E5934","DOI":"10.1073\/pnas.1612559113","volume":"113","author":"J Tomas","year":"2016","unstructured":"Tomas J, Mulet C, Saffarian A, Cavin J-B, Ducroc R, Regnault B, et al. High-fat diet modifies the PPAR-\u03b3 pathway leading to disruption of microbial and physiological ecosystem in murine small intestine. Proc Natl Acad Sci U S A. 2016;113:E5934\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1704_CR44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.chom.2019.07.004","volume":"26","author":"LB Thingholm","year":"2019","unstructured":"Thingholm LB, R\u00fchlemann MC, Koch M, Fuqua B, Laucke G, Boehm R, et al. Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host Microbe. 2019;26:252\u2013e26410.","journal-title":"Cell Host Microbe"},{"key":"1704_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55\u201360.","journal-title":"Nature"},{"doi-asserted-by":"crossref","unstructured":"Lal S, Kandiyal B, Ahuja V, Takeda K, Das B. Gut microbiome dysbiosis in inflammatory bowel disease. Progress in Molecular Biology and Translational Science [Internet]. Elsevier; 2022 [cited 2025 Mar 28]. pp. 179\u2013204. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117322001326","key":"1704_CR46","DOI":"10.1016\/bs.pmbts.2022.09.003"},{"key":"1704_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","volume":"73","author":"Y Shan","year":"2022","unstructured":"Shan Y, Lee M, Chang EB. The gut Microbiome and inflammatory bowel diseases. Annu Rev Med. 2022;73:455\u201368.","journal-title":"Annu Rev Med"},{"key":"1704_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177\u201385.","journal-title":"Nature"},{"key":"1704_CR49","first-page":"2999","volume":"16","author":"H Su","year":"2018","unstructured":"Su H, Kang Q, Wang H, Yin H, Duan L, Liu Y, et al. Effects of glucocorticoids combined with probiotics in treating Crohn\u2019s disease on inflammatory factors and intestinal microflora. Exp Ther Med. 2018;16:2999\u20133003.","journal-title":"Exp Ther Med"},{"key":"1704_CR50","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/nu11040818","volume":"11","author":"T Shinde","year":"2019","unstructured":"Shinde T, Perera AP, Vemuri R, Gondalia SV, Karpe AV, Beale DJ, et al. Synbiotic supplementation containing whole plant sugar cane fibre and probiotic spores potentiates protective synergistic effects in mouse model of IBD. Nutrients. 2019;11:818.","journal-title":"Nutrients"},{"key":"1704_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.clnesp.2023.07.087","volume":"57","author":"A Mahapatro","year":"2023","unstructured":"Mahapatro A, Bawna F, Kumar V, Daryagasht AA, Gupta S, Raghuma N, et al. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: an umbrella study on meta-analyses. Clin Nutr ESPEN. 2023;57:475\u201386.","journal-title":"Clin Nutr ESPEN"},{"key":"1704_CR52","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.numecd.2024.05.017","volume":"34","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Mahapatro A, Korsapati RR, Korsapati AR, Jain SM, Babaeizad A, et al. Exploring the relationship between gut Microbiome modulation and blood pressure in type 2 diabetes: an umbrella review. Nutr Metabolism Cardiovasc Dis. 2024;34:2046\u201354.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"1704_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15:261\u201373.","journal-title":"Nat Rev Endocrinol"},{"key":"1704_CR54","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.immuni.2019.09.020","volume":"51","author":"A Christ","year":"2019","unstructured":"Christ A, Lauterbach M, Latz E. Western diet and the immune system: an inflammatory connection. Immunity. 2019;51:794\u2013811.","journal-title":"Immunity"},{"key":"1704_CR55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000051878","volume":"63","author":"M Simr\u00e9n","year":"2001","unstructured":"Simr\u00e9n M, M\u00e5nsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, et al. Food-related Gastrointestinal symptoms in the irritable bowel syndrome. Digestion. 2001;63:108\u201315.","journal-title":"Digestion"},{"key":"1704_CR56","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","volume":"67","author":"PD Cani","year":"2018","unstructured":"Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67:1716\u201325.","journal-title":"Gut"},{"key":"1704_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40168-018-0433-4","volume":"6","author":"PM Miranda","year":"2018","unstructured":"Miranda PM, De Palma G, Serkis V, Lu J, Louis-Auguste MP, McCarville JL, et al. High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome. 2018;6:57.","journal-title":"Microbiome"},{"key":"1704_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1249\/JES.0000000000000183","volume":"47","author":"LJ Mailing","year":"2019","unstructured":"Mailing LJ, Allen JM, Buford TW, Fields CJ, Woods JA. Exercise and the gut microbiome: A review of the evidence, potential mechanisms, and implications for human health. Exerc Sport Sci Rev. 2019;47:75\u201385.","journal-title":"Exerc Sport Sci Rev"},{"key":"1704_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-022-00685-9","volume":"20","author":"AC Fenneman","year":"2023","unstructured":"Fenneman AC, Weidner M, Chen LA, Nieuwdorp M, Blaser MJ. Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the Gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2023;20:81\u2013100.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1704_CR60","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S2468-1253(20)30267-3","volume":"5","author":"LH Nguyen","year":"2020","unstructured":"Nguyen LH, \u00d6rtqvist AK, Cao Y, Simon TG, Roelstraete B, Song M, et al. Antibiotic use and the development of inflammatory bowel disease: a National case-control study in Sweden. Lancet Gastroenterol Hepatol. 2020;5:986\u201395.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1704_CR61","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41574-024-00966-0","volume":"20","author":"LMM Vliex","year":"2024","unstructured":"Vliex LMM, Penders J, Nauta A, Zoetendal EG, Blaak EE. The individual response to antibiotics and diet - insights into gut microbial resilience and host metabolism. Nat Rev Endocrinol. 2024;20:387\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"1704_CR62","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.3748\/wjg.v23.i22.3954","volume":"23","author":"E Utzeri","year":"2017","unstructured":"Utzeri E, Usai P. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. World J Gastroenterol. 2017;23:3954\u201363.","journal-title":"World J Gastroenterol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01704-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T06:03:01Z","timestamp":1745820181000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01704-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1704"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01704-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"type":"electronic","value":"1758-5996"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Decalarations"}},{"value":"This study utilized publicly available data and summary statistics from previously published genome-wide association studies (GWAS). No new data were collected specifically for this study, and no additional ethics approval or consent to participate was required for this MR study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}